Newsmeme!
Discover News you didn't know existed
NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said today that it has licensed technology from ActivX Biosciences that it plans to use to develop new mass spectrometry analysis and sample enrichment tools.
New England Biolabs said last week that it will supply next-generation sequencing library construction reagents to the Wellcome Trust Sanger Institute.
NEW YORK (GenomeWeb News) – Amsterdam-based Agendia said today that New York regulators have granted the firm a clinical laboratory permit, enabling it to receive commercial samples for its MammaPrint breast cancer recurrence assay from NY state residents.
Sirshendu Roopom Banerjee has been appointed as president and CEO of RainDance Technologies . He replaces Chris McNary , who will stay with the company as chief commercial officer.
SoftGenetics has released a new haplotype analysis application for its GeneMarker genotyping software. According to the company, the addition eliminates errors that arise from manually transferring data from genotyping software to pedigree analysis software.
Have strong feelings on the NIH grant review process? Well, here's your chance to sound off and vent your frustrations with a reader poll over at DrugMonkey's place . The purpose of the poll is to determine whether the number of summary statements and the review service changes the way researchers view the alleged flaws in the review process.
RainDance Technologies has appointed Sirshendu Roopom Banerjee to be company president and CEO.
Roche NimbleGen said last week that it has certified genomics service provider Atlas Biolabs to provide target-enrichment and sequencing services using its technologies.
At Science Progress, Scripps' Jeanne Loring explores the possibility that American researchers will soon be outsourcing their sequencing projects to China . China's sequencing capability is growing rapidly, she writes, pointing out that BGI has ordered 128 Illumina sequencers, bringing the total number of sequencers there to 157 — nearly double what the Broad Institute has.
NEW YORK (GenomeWeb News) – Sequenom today said that it has licensed from Optherion exclusive worldwide rights to intellectual property covering diagnostic tests for genetic predisposition to late-stage age-related macular degeneration.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |